UNSPSC 51144500: Stimulant or anorexiant pyrrolidines

This classification denotes compounds based on tetrahydropyrrole or C4H9N, substances called pyrrolidines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term STIMULANT OR ANOREXIANT PYRROLIDINES.

UNSPSC 51144500 Stimulant or anorexiant pyrrolidines is a Class code that in recent state and local procurement activity does not align with its nominal scope. The three most recent opportunities posted under this code involve naloxone (an opioid antagonist used in overdose response), safe drug deactivation systems, direct-to-manufacturer pharmacy benefit contracting, and generic multi-source pharmaceuticals with over-the-counter products — none of which are stimulant or anorexiant pyrrolidines. The mismatch suggests either miscoding by the issuing bodies or a data-classification artifact that does not reflect actual procurement intent under the code's stated commodity definition.

The recent opportunities span Seminole County, Florida (an IFB for naloxone and drug deactivation systems with a response deadline of July 26, 2023), the Texas Health and Human Services Commission (an RFI on direct-to-manufacturer prescriptions posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance (an RFP for generic multi-source pharmaceuticals and OTC products due March 26, 2026). Geographic coverage includes Florida, Texas, Minnesota, and Oregon (through MMCAP's multi-state membership). Because the recent solicitations tagged under this code do not represent the commodity class as named, practitioners should verify coding accuracy before investment in pursuit strategies under UNSPSC 51144500.